InsidersTradesSigma
아스테라시스 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 아스테라시스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 아스테라시스 has published 31 reports. Market capitalisation: €262.3bn. The latest transaction was disclosed on 12 June 2026 (Other). Among the most active insiders: 서은택. The full history is accessible without an account.
31
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 아스테라시스 Strong Buy (bullish).
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,554 of 26,213 companies
66.2
score / 100
Value44
Quality89
FCF yld1.5%
Earn yld3.9%
EV/EBITDA18.9x
ROE19%
Gross mgn79%
Net mgn24%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 June 2026
Declarations31 total
25 of 31 declarations
About 아스테라시스
Asterasis is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.